Pricey COVID-19 antibody treatment gets WHO approval

Posted by on September 24, 2021 8:58 am
Categories: Global Stories

The two antibodies, casirivimab and imdevimab, should be given to people infected with COVID-19 who are at highest risk of hospitalization or who have weak immune systems.

Leave a Reply

Your email address will not be published. Required fields are marked *